20th Jul 2016 07:00
GlaxoSmithKline plc (the 'Company')
Transaction notification
1. | Details of PDMR/person closely associated with them ('PCA') | |||||||||||||||||||||||
a) | Name | Ms C Thomas | ||||||||||||||||||||||
b) | Position/status | SVP, HR | ||||||||||||||||||||||
c) | Initial notification/ amendment | Initial notification | ||||||||||||||||||||||
2. | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||||||||||||||||||||||
a) | Name | GlaxoSmithKline plc | ||||||||||||||||||||||
b) | LEI | 5493000HZTVUYLO1D793 | ||||||||||||||||||||||
3. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted | |||||||||||||||||||||||
a) | Description of the financial instrument | Ordinary shares of 25 pence each ('Ordinary Shares') ISIN: GB0009252882 | ||||||||||||||||||||||
b) | Nature of the transaction | Increase in notional interest in Ordinary Shares following the re-investment of dividends paid to shareholders on 14 July 2016 on Ordinary Shares held in the Company's 2009 Deferred Annual Bonus Plan.
| ||||||||||||||||||||||
c) | Price(s) and volume(s) |
| ||||||||||||||||||||||
d) | Aggregated information
Aggregated volume Price |
1,065.862 £16.285
| ||||||||||||||||||||||
e) | Date of the transaction | 2016-07-14 | ||||||||||||||||||||||
f) | Place of the transaction
| n/a | ||||||||||||||||||||||
Related Shares:
Glaxosmithkline